Interim Effectiveness Estimates of 2023 Southern Hemisphere Influenza Vaccines in Preventing Influenza-Associated Hospitalizations - REVELAC-i Network, March-July 2023.

Saved in:
Bibliographic Details
Title: Interim Effectiveness Estimates of 2023 Southern Hemisphere Influenza Vaccines in Preventing Influenza-Associated Hospitalizations - REVELAC-i Network, March-July 2023.
Authors: Fowlkes AL, Nogareda F, Regan A, Loayza S, Mancio JM, Duca LM, Couto P, Leite J, Rodriguez A, Salas D, Azziz-Baumgartner E
Corporate Authors: REVELAC–i Network
Source: MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2023 Sep 15; Vol. 72 (37), pp. 1010-1015. Date of Electronic Publication: 2023 Sep 15.
Publication Type: Journal Article
Journal Info: Publisher: U.S. Centers for Disease Control Country of Publication: United States NLM ID: 7802429 Publication Model: Electronic Cited Medium: Internet ISSN: 1545-861X (Electronic) Linking ISSN: 01492195 NLM ISO Abbreviation: MMWR Morb Mortal Wkly Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1545-861X
DOI:10.15585/mmwr.mm7237e1